← SynDRA
PYRAZOLOACRIDINE
SynDRA canonical compound SYN0004316 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | TOP1 | TOP2A |
| Mechanism of action | rna synthesis inhibitor | topoisomerase inhibitor |
| Indication | melanoma |
| Disease area | oncology |
All known targets
Mechanisms of action (all sources)
- rna synthesis inhibitor
- topoisomerase inhibitor
- Modulator
Cross-references
Synonyms
- NSC-366140
- NSC-627168
- PD-115934
- 2-[3-(Dimethylamino)propyl]-9-methoxy-5-nitro-2,6-dihydropyrazolo[3,4,5-kl]acridine
- 9-Methoxy-N,N-dimethyl-5-nitro-2,6-dihydropyrazolo[3,4,5-kl]acridine-2-propanamine
- PD 115934
- NSC 366140
- L24XJN68OW
- RefChem:177465
- DTXCID901440628
- NSC627168
- Pyrazolo-acridine (free base)
- NSC 366140; NSC 627168; PD 115934; PZA
- UNII-L24XJN68OW
- BRN 4211902
- CCRIS 9408
- PD 115,934
- NCIMech_000572
- Neuro_000206
- Neuro_000260
- SCHEMBL867991
- orb1304938
- SCHEMBL6350605
- SCHEMBL29373084
- HZCWPKGYTCJSEB-UHFFFAOYSA-N
- CCG-35612
- AKOS024419418
- AKOS040749252
- SB17160
- MS-25883
- NCI60_003371
- NCI60_008612
- PD132328
- 2-[(3-N',4,5-kl]acridine, free base
- DS-001689
- HY-108969
- CS-0033826
- NS00069178
Look up PYRAZOLOACRIDINE in the interactive SynDRA portal →